Vertical Peak Holdings Inc. (SPLIF)
| Previous Close | 0.0040 |
| Open | 0.0040 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0040 - 0.0040 |
| 52 Week Range | 0.0015 - 0.2918 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 770,424 |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Apr 19, 2024 - Apr 20, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Vertical Peak Announces LOI to Sell California Operation and Board of Director Change
Vancouver, British Columbia--(Newsfile Corp. - August 17, 2023) - Vertical Peak Holdings Inc. (CSE: MJMJ) (OTC PINK: SPLIF) (formerly High Fusion Inc.) ("Vertical Peak" or the "Corporation") wishes to announce that it has entered into binding letter of intent ("LOI") dated August 9, 2023 to sell all its California operations ("Transaction") to Downwind Holdings Inc. ("DHI").Transaction OverviewPursuant to the terms of the LOI, DHI agreed to acquire from Vertical Peak all assets relating to ...
NewsfileVertical Peak and Neural Therapeutics Announce Completion of the Plan of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2023) - Vertical Peak Holdings Inc. (CSE: MJMJ) (formerly High Fusion Inc.) ("Vertical Peak" or the "Corporation") and Neural Therapeutics Inc. ("Neural"), are pleased to announce closing of the previously announced proposed spin-out of Neural through a plan of arrangement under the British Columbia Business Corporations Act (the "Plan of Arrangement"), pursuant to the amended and restated arrangement agreement dated February 24, 2023 ("Arra
NewsfileVertical Peak Announces Record Date and Targeted Effective Date for the Spin-Out of Neural Therapeutics
Vancouver, British Columbia--(Newsfile Corp. - May 17, 2023) - Vertical Peak Holdings Inc. (CSE: MJMJ) (OTC Pink: SPLIF) ("Vertical Peak" or the "Corporation") is pleased to announce an update on the previously announced proposed spin-out of a portion of its holdings of common shares ("Neural Shares") of Neural Therapeutics Inc. ("Neural") through a plan of arrangement under the Business Corporations Act (British Columbia) (the "Plan of Arrangement").All of the conditions precedent to completion
